We have previously demonstrated the presence of rhesus monkey papillomavirus type 1 (RhPV-1), from molecular and pathological evidence, in a mating group within a single institution. We have now also obtained a number of fresh or archival tissues of rhesus monkeys from other geographically distinct institutions. Using PCR amplification, we observed two animals from one of these institutions and five animals from another which demonstrated RhPV-1 DNA sequences. In addition we molecularly cloned the E7, E2, E4, L2 and L1 genes of RhPV-1 into bacterial expression vectors. The fusion gene products were used to test for serological response to RhPV-1 antigens by Western blot analysis. Responses were observed in up to 52 % of the animals tested. While some serologically positive animals were also RhPV-1 DNA-positive, most were not.
Introduction
Rhesus papillomavirus type 1 (RhPV-1) was recently isolated from a male rhesus monkey (Maccaca mulatta) with a penile carcinoma (Kloster et al., 1988) . Subsequently other animals at the same facility were tested for the presence of the virus by molecular and pathological techniques (Ostrow et al., 1990) . About 40% of the tested animals which were within the same mating cohort as the male rhesus monkey were found to have RhPV-1 DNA and/or evidence of genital neoplasia consistent with papillomavirus infection. The apparent sexual transmission and high oncogenic potential of this virus closely mimics the natural disease associated with the highly oncogenic genital human papillomaviruses (HPVs). The prevalence of RhPV-1 infections in various breeding and study populations is currently unknown. We have been testing tissue samples from various sources for other possible infected populations. In some cases only fixed tumour tissue and/or archival sera were available for study.
Various serological methods have recently been used to augment molecular analyses for HPV infections.
* Author for correspondence. Fax + 1 612 626 7031. e-mail ron@molbio.cbs.umn.edu These studies have involvedproducing various gene products of papillomaviruses in bacterial expression vectors for use in Western blot assays of humoral antibodies (Barber et al., 1992; Ghosh et al., 1993; Jenison et al., 1990 Jenison et al., , 1991 Jochmus-Kudielka et al., 1992; Kochel et al., 1991) . The genes useful in such studies include E7, which is known to interact with the retinoblastoma gene product, a cellular tumour suppressor gene (Gage et al., 1990) ; E2, which is a transactivating protein important for control of early gene expression (Guido et al., 1992) ; E4, which, although its function has not been delineated, is usually a fairly abundant protein in productively infected cells Jochmus-Kudielka et al., 1992; Onda et al., 1993) ; and L2 and L1, which are structural proteins (Kirnbauer et al., 1992) . Using either Western blot or ELISA techniques, significant correlations have been demonstrated between antibodies to HPV-16 E7 and cervical cancer compared to controls (Ghosh et al., 1993 ; Jochmus-Kudielka et al., 1992; Kochel et al., 1991; Such~inkov~i et al., 1991 Such~inkov~i et al., , 1992 . In some studies, antibodies to HPV-16 E4 have shown positive correlations in cancer patients compared to controls (Jochmus-Kudielka et al., 1992; Kochel et al., 1991) and in studies on patients with premalignant disease, levels of both E4 and L2 antibodies were found to be higher when compared to controls (Barber et al., 1992) 
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Such methodology complements molecular studies and also makes assays possible where tissue samples may not be readily available. In this report we describe the detection of RhPV-1 DNA in fixed tissue of rhesus monkeys from a new facility and the detection of antibodies to RhPV-1 gene products in animals from that facility. Both molecular and serological evidence were also obtained for papillomavirus infections at other geographically distinct institutions.
Methods
Clinical material. With one exception, all materials were obtained from female Rhesus monkeys. Fixed archival tissues from 1985 were obtained from the R. W. Johnson Pharmaceutical Research Institute (RWJPRI). Freshly frozen cervical smears were obtained from the Tulane Regional Primate Research Center (TRPRC). Serological specimens were obtained from each of these two institutions as well as the Wisconsin Regional Primate Research Center (WRPRC), and from the Harlow Primate Laboratory (HPL), where we had previously demonstrated RhPV-1 infections using molecular and pathological evidence (Ostrow et al., 1990) . Animals from RWJPRI were caught in the wild in approximately 1975 and individually housed. Although records are not available, it is believed most of these animals came from India, and a few from other areas of the Far East. Founder animals from WRPRC and HPL were obtained from various importers from approximately 1960 to 1978, when India outlawed the exportation of rhesus monkeys. The colony was split between WRPRC and HPL in 1974-1975 , with the majority of animals remaining at WRPRC. After 1975, separate breeding colonies existed, though with common ancestors. Of the 13 HPL animals, only four monkeys were laboratoryborn. Of the 50 WRPRC animals, only two were feral. These animals have lived in social groups which permitted sexual interactions within each facility. The animals from these two centres are largely separate groups, and were only infrequently exchanged. The animals from TRPRC included eight of Chinese origin and 42 of Indian origin. Nineteen of these 42 animals were born at TRPRC. The animals at TRPRC have also lived in social groups permitting sexual interactions. We have included serum samples from animals previously tested for RhPV-I DNA (Ostrow et al., 1990) . This included serum from the index male from which RhPV-1 was first isolated (Kloster et al., 1988) . In some cases, only tissue or only serum samples were available from individual animals at the various locations.
DNA analysis. The methods for total DNA extraction from fixed tissues, and PCR amplification and Southern blot detection of the resulting products have been described previously (Ostrow et al., 1990) . Briefly, formalin-fixed tissues were washed with ethanol to remove the formalin and dried. The tissues were subsequently treated with proteinase K and detergent and phenol~zhloroform extracted, before being concentrated by ethanol precipitation. The nucleic acids were treated with RNase and again extracted as above. Tissues were extracted with fresh reagents using a positive displacement Pipetman (Gilson) in a room separate from that used for PCR analysis. Simultaneous extraction of fixed tissues from normal rhesus monkeys (known from previous assays to be RhPV-1 DNA-negative) or from chicken fibroblasts served as negative controls for extraction and for PCR. Total cellular DNA (1-2 gg) was amplified with oligonucleotide primers for RhPV-1 E6 (15' GCGAGCAGCGTGAGGAGA 3', 5' GCAAGAAACTACTGCCC 3'), E7 [5' ATAA TAAGCTTGCAA-GCATGATTGG 3', 5' CTGGTGAAGCTTCAGGGTCC 3', containing modifications (italics) at the 5' end, which introduce restriction endonuclease sites (underlined) used in other projects but which are also useful for detection analyses], or for a rhesus monkey DRB locus (5' CATTTCTTCAATGGGACGGA 3', 5' CCGCTGCACTGTGA-AGCTCT 3'). Samples were denatured for 5 min at 94 °C, amplified by 40 cycles of PCR at 94 °C for 0.5 min, 50 °C for 0.5 rain and 72 °C for 1 min, and finally treated at 72 °C for 10 min. Portions (20% of total reaction volume) of each reaction were subsequently analysed by blotting using 1.6 % (w/v) agarose gets (3:1 w/w FMC Bioproducts NuSieve GTG agarose: IBI agarose) followed by transfer to nitrocellulose and hybridization with respective gene-specific PCR probes derived from nested primers under conditions of high stringency (Ostrow et al., 1990) . We estimate that 30-50 fg of target genomic RhPV-1 plasmid DNA can be detected by this method.
Production of RhPV-1 fi,sion proteins.
Various open reading frames (ORFs) of RhPV-1 were molecularly cloned into bacterial pATH expression vectors (kindly provided by T. J. Koerner, American Cancer Society, Atlanta, Ga., USA) to produce large amounts of these viral proteins fused to the trpE gene product (Firzlaffet al., 1987; Jenison et al., 1988) . The E7 region of the RhPV-1 genome (nt 594~935) was amplified by PCR using oligonucleotide primers containing EeoRI and SalI sites and subsequently cloned into the vector pATH11 to produce a fusion product of approximately 60kDa. The E2 region (nt 2746-3965) was excised with BsmAI restriction endonuclease, filled in with the Klenow fragment of DNA polymerase and subsequently EcoRI linkers were added for cloning into the vector pATHI, to produce a fusion protein of 77 kDa. The E4 region was obtained by cleavage with Nsil and ScaI (nt 3353-3897), blunted and cloned into the ClaI (blunted) and PstI sites of pATH10 to produce a 48 kDa fusion protein. Portions (nt 4598 6689) containing L2 were isolated by cleavage with Bsu36I, BamHI and Hind]II, and were subsequently cloned into the EcoRI and HindIII sites of pATH 11 to produce a fusion protein of about 110 kDa. Finally, L1 was obtained by cleavage with TaqI (nt 6061-7665) and cloned into pATH 11 which had been cleaved with EcoRI and SalI, and blunt-ended, producing a fusion protein of about 86 kDa.
Western blot assays. Western blot assays were performed as described previously (Jenison et al., 1988; Sambrook et aL, 1989) . Briefly, test sera were first preincubated with lysed bacteria containing a trpE expression plasmid to block non-specific interactions with bacterial epitopes. Fusion proteins were induced in bacteria, partially purified and separated by electrophoresis under denaturing conditions through polyacrylamide gels. The proteins were electrophoretically transferred to a nitrocellulose membrane and then incubated with a 1 : 50 dilution of the blocked sera. Blots were then washed, treated with alkaline phosphatase-conjugated Protein A, which binds to antibodies. This was then treated with 5-bromo-4-chloro-3-indolyl phosphate/nitro blue tetrazolium, which produces a precipitate on the membrane where the conjugate binds to rhesus monkey antibodies. Positive and negative controls consisted of sera from animals previously found to have or not have RhPV DNA infections or antibody reactivity. No responses were observed on blots using protein derived from the trpE expression plasmid without RhPV-1 genes. Samples were analysed ~blind' and some of the samples were repeated to ensure reproducibility.
Results

DNA analysis of fixed tissues
Three archival samples of cervical tissues in formalin were submitted for RhPV-1 DNA analysis by the RWJPRI. One tissue (5B012) was a cervical cancer which occurred during the course of a drug study on a series of feral rhesus monkeys. It was a poorly differentiated squamous cell carcinoma with focal areas of adeno- RhPV-1 DNA using E6-specific primers. DNA extracted from various fixed cervical samples from rhesus monkeys was analysed for RhPV-1 DNA using oligonucleotide primers specific for the E6 ORF in PCR amplification followed by Southern blot analysis with a radiolabelled E6 DNA probe (Ostrow et aL, 1990) . The arrow indicates the position of the 432 bp product, which was produced from a positive control RhPV-1 DNA-containing plasmid. (b) Detection of a DRB gene locus by PCR analysis. DNA samples were analysed using a pair of oligonucleotide primers specific for a DRB nucleotide sequence found squamous carcinoma. The second (5B016) was a normal cervical tissue from another animal that received similar treatment, and the third (5A067) was a normal cervical tissue from a control animal in the study. Total cellular DNA was extracted from each under conditions which minimize possible cross-contamination from other samples, existing plasmids or PCR amplicons. Positive and negative control tissues were extracted for D N A at the same time as the test samples. Positive controls consisted of a formalin-fixed biopsy of rhesus monkey cervical tissue previously found to contain RhPV-1 DNA (AI09; Ostrow et al., 1990) . Negative controls consisted of fixed rhesus monkey cervical tissues previously found to be negative for RhPV-1 D N A (PP108 and RhAN27; Ostrow et al., 1990; R. Ostrow, unpublished observation) and DNA from chicken fibroblasts. In addition, buffer controls and RhPV-1 plasmid controls were used. Each DNA was then amplified with oligonucleotide primers specific for the E 6 0 R F of RhPV-1. One fifth of each reaction mixture was analysed by Southern blot hybridization (Ostrow et al., 1990) . The results are shown in Fig. 1 (a) . Positive hybridization to a PCR product of 432 nucleotides was observed in samples 5B016, 5A067 and AI09, but not in DNA from 5B012 or negative control samples (PP108 and RhAN27; Fig.  1 a) . While positive bands in some of the fixed samples were weak, they were reproducible in replicate PCR amplifications and from duplicate extractions of tissue. These signals were markedly enhanced by a second round of PCR amplification (data not shown). Similar results were obtained using a set of primers for RhPV-1 E7, which produce a product of 377 bp (data not shown). In order to establish whether the quality of extracted D N A was adequate for analysis, samples were also analysed by PCR amplification using primers which share high homology with the rhesus monkey DRB gene locus, and other monkey and human DRB gene loci (unpublished observation). These produce a 234 bp product upon amplification (Fig. 1 b) . Bands of appropriate size for the DRB locus were observed in all samples except 5B012, indicating that the quality of the DNA from only the latter sample was not adequate for analysis.
D N A analysis o f frozen cervical smears
D N A was extracted from 46 frozen cervical smears from TRPRC and analysed by PCR amplification using RhPV-1 E6 primers as above. Five of the samples were in rhesus monkeys and a rhesus DRB DNA probe. The arrow indicates the position of the 234 bp product produced from RhPV-1 DNA templates. found to contain RhPV-1 E6 sequences. A typical blot is shown in Fig. 2 . In a short exposure (Fig. 2a) , one sample, H977, is clearly positive for RhPV-1 D N A . N o hybridization was observed in a buffer blank (lane 13). However, in extended exposures positive hybridizations were also observed for samples H528 and I748 (Fig. 2b) .
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Analysis of sera for presence of antibodies to RhPV-1
Sera from 58 rhesus monkeys from the R W J P R I were tested by Western blot analysis for antibodies to various gene products from RhPV-1 (Table t) . Partially purified trpE fusion products for the RhPV-1 E7, E2, E4, L2 and L 1 0 R F s were used for Western blot assays (Fig. 3 a) . A n example of positive results is shown in Fig. 3 (b) . Of the sera tested, 22 (38 %) were positive for antibodies to one or more RhPV-1 gene, Ten (17%) of the sera showed a positive response to two or more viral proteins. Interestingly, each o f the sera from the three animals from which fixed tissues were obtained for D N A analysis were found to be serologically positive. The animal with the cervical tumour had a response to L2 and E2 fusion proteins while one animal had a positive response to L2 alone, and the other animal to both L2 and E7 fusion proteins. Sera were also tested from 50 animals from the W R P R C and 13 animals from the H P L that included animals which we had previously studied (Ostrow et al., 1990) . Twenty-two animals (44%) from W R P R C and eight animals (62 %) from H P L were positive for at least one R h P V -1 0 R F marker (Table 1) . Twenty-five (52 %) of the 48 available sera from the T R P R C animals also gave positive responses. The most prevalent gene reacting in all studies was L2 (25-54 % of animals), a structural gene of the virion.
Correlation of serological and molecular results
As indicated above, the two DNA-positive samples from the R W J P R I were both serologically positive. O f the 44 animals from the T R P R C on which both serological and molecular analyses were performed, four were positive for RhPV-1 by both methods and 21 out of these 44 were positive only by Western blot. Four o f the five D N Apositive samples from the T R P R C had matching sera for analysis, but all o f these were positive for antibodies to various combinations o f RhPV-1 fusion proteins. We were able to obtain sera from 13 of the animals from H P L which had previously been studied by molecular analysis (Ostrow et al., 1990) . Four were positive both (25) 10 (21) 25 (52) 4 (8) 4 (8) * Shown are the number of animals (%) that individually had positive Western blot responses to at least one, any two, or three or more RhPV-1 fusion proteins. analysis data from Ostrow et al. (1990) . Several new samples were repeated for this study. 
RhPV-1 infections in various populations
Discussion
Two of the three fixed archival cervical tissue samples from the RWJPRI were considered adequate for DNA analysis, as a genomic DRB sequence was successfully amplified. Both of these clinically normal tissue samples demonstrated evidence of the presence of both E6 and E7 genes of RhPV-1. The third tissue sample, a cervical cancer, was inadequate for PCR analysis. As such, we cannot say at this time using PCR analysis whether this animal had an RhPV-l-infected cervix. However, all three of these animals, as well as many of the other animals from the RWJPRI, exhibited antibodies to specific RhPV-1 genes. The concordance between the DNA and serological findings in the two normal cervical tissues would seem to confirm the presence of an RhPV-1 infection in these two animals, albeit in a latent state. The presence of RhPV-1 antibodies in the animal with a cervical cancer and the known high oncogenic capacity of RhPV-1 suggests that this cancer may have resulted from an RhPV-1 infection, but this is not certain. The Positive responses are clearly visible for antibodies to E7 and L2 fusion proteins. This image also detected a very faint response to E2 which was not detectable to the eye and was therefore not counted as a positive.
proportion of animals and the distribution of gene epitopes which was detected in the RWJPRI population was similar to that observed in a population of rhesus monkeys known to be sexually active with infected animals at the WRPRC, the HPL and in another population at the TRPRC. Archival serum from one of four animals tested at the University of Minnesota (Minn., USA) was also positive for RhPV-1 antibodies by Western blot analysis (data not shown). As is the case in other monkeys studied (Ostrow et al., 1990) , rhesus monkeys can be infected with RhPV-1 and not show disease. In this study, four animals out of 50 from the TRPRC had pathological evidence of papillomavirus infection of a minor nature. This parallels the many reports of HPV infections in the general population which do not exhibit disease. The significance of these latent infections is not clearly understood, as future disease progression is a result of many factors including genetic disposition, immune function, other viral infections and environmental cofactors. However, it is interesting that populations of rhesus monkeys in several parts of the USA have RhPV-1 infections. This fact can be very important where studies are conducted during which rare cervical cancers are observed. Such neoplasia may be due to a previous latent or active RhPV-1 infection which has been induced to progress and could be considered a possible complicating factor in various drug studies.
The correlation between RhPV-1 DNA positivity and serological positivity is overall not very good. Where both assays were performed, most of the RhPV-1 DNApositive animals in this study were also serologically positive (8/10); however, most serologically positive animals were not RhPV-1 D N A positive (23/31). Using similar Western blot technology with HPV-6, HPV-16 or HPV-18 ORF fusion proteins to study antibody response, other studies have had positive results of 75 %, 54 % and 27 % in sexually transmitted disease patients and 65%, 40% and 28%, respectively, in children . Response to the two late gene fusion proteins was clearly most frequent, particularly for L2 of HPV-16 and HPV-18, as we have observed in our study. There can be many complicating factors in these assays: (i) serological analysis may detect previous as well as current infections. Thus viral DNA may not be present in a serologically positive animal. Using HPV-6 L1 and L2 peptides in ELISA assays, men with previous condylomatous tumours had higher titres to the peptides than a control population, but those with current condylomata did not have higher titres (Wikstrom et al., 1992) ; (ii) viral DNA could have been missed as a result of a tissue sampling error. It has been demonstrated in humans that while detection of HPV infections from smear samples is effective, it can be variable upon repeat sampling, perhaps as a result of cyclic virion shedding ; (iii) on the other hand, an active RhPV-1 infection may not induce a detectable serological response, thus producing DNA-positive, serologically negative results; (iv) serum samples in the animals from the HPL were drawn several years after the molecular studies. It is possible that the two animals which were RhPV-1 DNA-negative but seropositive had become infected during the intervening period, or may represent the residue from an infection which preceded the molecular study; (v) the assay used in this study detected antibodies to linear epitopes of RhPV-1 in bacterial fusion proteins. While providing a rapid screening method which distinguishes specific bands proved useful in this study, even higher serological responses, particular for L1, may have been observed using eukaryotically expressed capsid proteins, which display conformational epitopes, using more cumbersome immunoprecipitation assays, or ELISA assays (Galloway, 1994; ; (vi) finally, one cannot rule out that there may be host antibodies directed against non-papillomavirus antigens which cross-react to the fusion proteins which we have generated. The presence of RhPV-1 DNA in some of these animals and the finding of a few animals with pathological evidence of infection would suggest that the serological response which we observed was genuine. However, while use of serological analyses such as these are relatively simple as an initial screening tool, they require additional tests to confirm active or latent RhPV-1 infections.
